Efficacy and Safety of Autologous Dendritic Cell-Based Immunotherapy, Docetaxel, and Prednisone Vs Placebo in Patients With Metastatic Castration-Resistant Prostate Cancer The Viable Phase 3 Randomized Clinical Trial

AuthID
 P-00W-604
26
Author(s)
Vogelzang, NJ
·
Beer, TM
·
Gerritsen, W
·
Oudard, S
·
Wiechno, P
·
Kukielka Budny, B
·
Samal, V
·
Hajek, J
·
Feyerabend, S
·
Khoo, V
·
[+6]·
Hussain, A
·
Bahl, A
·
Hussain, S
·
Fricke, H
·
Kadlecova, P
·
Scheiner, T
·
Korolkiewicz, RP
·
Bartunkova, J
·
Spisek, R
View all authors
1
Group Author(s)
VIABLE Investigators
Document Type
Article in Press
Year published
2022
Published
in JAMA ONCOLOGY, ISSN: 2374-2437
Volume: 8, Issue: 4, Pages: 546 (7)
Indexing
Wos®
Scopus®
Crossref®37
Pubmed®
Google Scholar®
Publication Identifiers
Pubmed: 35142815
Scopus: 2-s2.0-85125043224
Wos: WOS:000754028300007
Source Identifiers
ISSN: 2374-2437
Export Publication Metadata
Marked List
 Add to Marked List
Info
At this moment we don't have any links to full text documens.
All authors
Name Order Name   Name Order Name   Name Order Name
1 Vogelzang, NJ;   2 Beer, TM;   3 Gerritsen, W;
4 Oudard, S;   5 Wiechno, P;   6 Kukielka Budny, B;
7 Samal, V;   8 Hajek, J;   9 Feyerabend, S;
10 Khoo, V;   11 Stenzl, A;   12 Csoszi, T;
13 Filipovic, Z;   14 Goncalves, F;   15 Prokhorov, A;
16 Cheung, E;   17 Hussain, A;   18 Sousa, N ;
19 Bahl, A;   20 Hussain, S;   21 Fricke, H;
22 Kadlecova, P;   23 Scheiner, T;   24 Korolkiewicz, RP;
25 Bartunkova, J;   26 Spisek, R;  

footer slogan

Useful Links

Get Help

© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service